News
Investors pour $115 M into RQ Bio in search of a preventive flu drug
9+ hour, 13+ min ago (346+ words) The startup claims to have a "differentiated" antibody that can provide long-lasting protection against a variety of influenza strains. Biotechnology startup RQ Bio has snagged a nine-figure funding round to support development of a drug it believes to be capable…...
Parabilis, chasing "undruggable" targets, nabs $305 M amid VC funding blitz
5+ mon, 2+ week ago (25+ words) The financing, which will back a novel type of cancer drug, is the largest of a series of startup fundings'announced at the top of 2026....
GSK, Ionis claim study success for RNA-based hepatitis B drug
5+ mon, 2+ week ago (247+ words) The companies didn't provide details, but said global regulatory filings are now planned for the therapy, an oligonucleotide meant to provide "functional cures" for chronic hepatitis B infections. Health officials estimate that more than 2 billion people around the world have…...
Moderna says CMV vaccine once seen as future blockbuster fails key study
8+ mon, 1+ day ago (351+ words) A vaccine Moderna has long been developing for the world's most common congenital infection has failed a Phase 3 trial. "Today's announcement is disappointing for families and healthcare professionals who have been eagerly awaiting a CMV vaccine," Moderna CEO St'phane Bancel…...
Moderna's latest approval again reveals FDA rift over COVID vaccines
11+ mon, 1+ week ago (334+ words) Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children. Vinay Prasad, the head of the Food and Drug Administration office that regulates vaccines, overruled fellow agency…...